Navigation Links
MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
Date:12/15/2008

Live Broadcast on December 18, 2008 at 9 a.m. Eastern Time

VALENCIA, Calif., Dec. 15 /PRNewswire-FirstCall/ --MannKind Corporation (Nasdaq: MNKD) will host a live broadcast to review clinical results from its final two Phase 3 studies of AFRESA(TM), the company's ultra rapid acting, inhaled insulin product, at 9 a.m. Eastern Time on Thursday, December 18, 2008.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in viewing the live webcast via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (800) 873-5860 or (203) 369-3996. A replay will also be available on MannKind's website for fourteen days.

About AFRESA

Afresa is an ultra rapid acting inhaled insulin product that has completed Phase 3 trials. The pharmacokinetic profile of Afresa sets it apart from all other insulin products. The large surface area of the lung provides unique access to the circulatory system. The pH-sensitive Afresa particles immediately dissolve upon contact with the lung surface, releasing insulin monomers that rapidly enter the bloodstream. It achieves peak insulin levels within 12-14 minutes of administration, effectively mimicking the release of meal-time insulin observed in healthy individuals, but which is absent from patients with diabetes.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercializatio
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
2. MannKind Addresses Pfizers Announcement Regarding Exubera
3. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
4. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
6. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
9. Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
10. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
11. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 8, 2014, ... to listen to the live discussion via the internet ... at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the ... the live event and accessible at the links above ...
(Date:8/27/2014)... -- An experimental drug designed to help regulate the blood,s ... anemia of inflammation, according to results from the first human ... Blood , the Journal of the ... is a condition that occurs when red blood cells are ... individual has anemia, the body does not get enough oxygen, ...
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire/ ... market research report is available in ... Guidebook for Application and Approval of ... to Practices (2014 Edition) ... Now, Chinese regulations on ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... PDII ), today reported financial and operational results ... Summary financial and operating highlights include: Full year ... 2011 and 2010 revenue excludes the company,s Pharmakon business unit, ... in discontinued operations. Full year 2011 operating loss of $4.7 ...
... March 7, 2012  The Starkey Hearing Foundation Israel-Palestine Hearing ... Palestinians together for a common cause to address a ... a year, Starkey Hearing Foundation, which strives to change ... visited the region in an effort to promote greater ...
Cached Medicine Technology:PDI Reports 2011 Fourth Quarter and Year End Financial Results 2PDI Reports 2011 Fourth Quarter and Year End Financial Results 3PDI Reports 2011 Fourth Quarter and Year End Financial Results 4PDI Reports 2011 Fourth Quarter and Year End Financial Results 5PDI Reports 2011 Fourth Quarter and Year End Financial Results 6PDI Reports 2011 Fourth Quarter and Year End Financial Results 7PDI Reports 2011 Fourth Quarter and Year End Financial Results 8PDI Reports 2011 Fourth Quarter and Year End Financial Results 9PDI Reports 2011 Fourth Quarter and Year End Financial Results 10Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 2Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 3Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 4Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 5
(Date:8/27/2014)... Washington, DC (PRWEB) August 28, 2014 ... that Betty Pierce Dennis, DrPH, MN, RN, FAAN, became ... Nursing Center for the Advancement of the Science of ... one of seven that comprise the NLN Home for ... the nation’s capital a year ago. , Under ...
(Date:8/27/2014)... Delta, a reliable supplier of high quality ... D7R Dozers to its used bulldozer collection. ... that all these items are offered with deep discounts. ... Delta’s market share in the coming September. , ... offer; he has much confidence in the discounted Used ...
(Date:8/27/2014)... 27, 2014 Millennium Treatment Group is ... for Florida Mental Health Counselors Association (FMHCA). The addiction ... sponsorship is sure to provide. , FMHCA is an ... Florida’s licensed mental health counselors. The organization was founded ... Association (ACA) and since then, it has served the ...
(Date:8/27/2014)... Mamaroneck, NY (PRWEB) August 27, 2014 ... Mobility Team ) is holding free events about “ ... guest speaker Liz Treston. These straightforward and entertaining discussions ... pm at Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) ... (500 Central Avenue, Bethpage, NY). , The New ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... released guidelines for the management and treatment of ... for Pulmonary Arterial Hypertension in Adults: CHEST Guideline, ... to view for clinicians, and provide the latest ... The Pulmonary Hypertension Association (PHA) – ...
Breaking Medicine News(10 mins):Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Millennium Treatment Group Sponsors Florida Mental Health Counselors Association 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2
... factors associated with multiple sclerosis previously poorly understood ... alter a critical cellular function linked to the chronic ... Research Center have discovered. The findings, which appear ... a unifying mechanism may be responsible for multiple sclerosis ...
... finds that obese women reported significantly worse health than obese ... blacks in the normal or obese weight categories. Respondents were ... their height and weight. The survey results are ... Quality of Life Research and they come from a ...
... Elsevier, a world-leading publisher of scientific, technical and ... the launch of a new journal, International Journal ... Association. Published quarterly, the first issue of the journal ... ScienceDirect. Print copies of the first issue will be ...
... true that we know of around 70 different types of ... were diagnosed correctly when we began the study", say researchers ... study included 176 patients, the vast majority from the cities ... at specialist geriatric psychiatry clinics during the period 1996-2006 and ...
... has launched a network of job sites designed to ... audience that uses Springer tools which are some of ... research. With over 16 million unique visitors per month ... and medical specialities, Springer,s sites attract the candidates that ...
... 30, 2011 Private health clinics across Canada providing weight-loss ... hefty cost and at the expense of quality patient care, ... physician Dr. Chaim Bell. "The private clinics in ... that involves banding the upper stomach to restrict food intake ...
Cached Medicine News:Health News:UCI researchers find link between environment and genetics in triggering MS 2Health News:Extra weight equals better health-related quality of life for blacks, not so for women 2Health News:Elsevier launches new journal: International Journal of Paleopathology 2Health News:Difficulties in diagnosing dementia type 2Health News:Springer launches network of job sites 2Health News:Private weight-loss surgery clinics shedding quality patient care 2
The ACMI TurboFlow 18 L and 10 L Insufflators provide rapid distention for all laparoscopic procedures. Eleven built-in safety features make insufflation reliable and dependable....
Tongs...
... Ambient Noise Reduction (ANR)technology, internal to ... 75% of distracting room,noise, greatly enhancing ... is different from electronic filtering, which ... of body sounds clinicians need to ...
... leaded eyeglasses deliver superb radiation protection-0.62mm (+/- ... procedures. In addition to their level of ... light-weight and rest smoothly on your bridge ... If you normally wear corrective lenses, you ...
Medicine Products: